BDBM316321 2-(2-(3-Chlorophenyl)-4-oxo-6-(3-(piperidin-1-ylmethyl)cyclobut-1-en-1-yl)quinazolin-3(4H)-yl)-N-isopropylacetamide::US9617226, Example 1

SMILES CC(C)NC(=O)Cn1c(nc2ccc(cc2c1=O)C1=CC(CN2CCCCC2)C1)-c1cccc(Cl)c1

InChI Key InChIKey=AWYZATAQWGHTSO-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 316321   

TargetVasopressin V1a receptor(Homo sapiens (Human))
Abbvie Deutschland

US Patent
LigandPNGBDBM316321( 2-(2-(3-Chlorophenyl)-4-oxo-6-(3-(piperidin-1-ylm...)
Affinity DataKi:  55nMAssay Description:The binding assay was carried out by the method based on that of Tahara et al. (Tahara A et al., Brit. J. Pharmacol. 125, 1463-1470 (1998)).The incub...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent